R&D News | pharmaphorum

News

The FDA has rounded out its senior leadership by naming biopharma industry executive George Tidmarsh to the role of CDER director.

News

Can survival data from the FLAURA2 trial of Tagrisso help AstraZeneca fend off a challenge from J&J's fast-growing rival in EGFR-mutated lung cancer?

News

Roche gambled on an all-comer design for trials of its COPD candidate astegolimab, a move that may prove costly as it fails a phase 3 test.

News

The UK government has revealed a plan to open a multibillion-pound biosecurity facility to protect the country from emerging public health threats.

News

Bayer's chief executive Bill Anderson looks set to keep his role until nearly the decade, as his turnaround plan starts to deliver results.

News

The UK has unveiled its plan to revitalise the life sciences sector and become a global leader by 2030, but a pharma trade group says it falls short.